Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Interim first-in-human data released on two c-Met inhibitors

Oct. 19, 2011

AB Science recruits first patient in phase III masitinib trial

Oct. 18, 2011

Infinity Pharmaceuticals provides update on IPI-926 trials

Oct. 18, 2011

Novel autotaxin inhibitors designed by Merck KGaA

Oct. 18, 2011

ABI-007 advances through trial in gastric cancer

Oct. 18, 2011

First-in-patient study assesses EMD-525797 in metastatic CRPC

Oct. 18, 2011

Results made available from MENZA trial of enzastaurin

Oct. 18, 2011

Epizyme triggers milestone payment in HMT therapeutic alliance with GSK

Oct. 17, 2011

Dana-Farber Cancer Institute claims new protein kinase inhibitors

Oct. 17, 2011

Cylene Pharmaceuticals advances CX-5461

Oct. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...